132 related articles for article (PubMed ID: 29883536)
1. Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi.
Martín-Escolano R; Moreno-Viguri E; Santivañez-Veliz M; Martin-Montes A; Medina-Carmona E; Paucar R; Marín C; Azqueta A; Cirauqui N; Pey AL; Pérez-Silanes S; Sánchez-Moreno M
J Med Chem; 2018 Jul; 61(13):5643-5663. PubMed ID: 29883536
[TBL] [Abstract][Full Text] [Related]
2. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
[TBL] [Abstract][Full Text] [Related]
4. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives.
Paucar R; Martín-Escolano R; Moreno-Viguri E; Cirauqui N; Rodrigues CR; Marín C; Sánchez-Moreno M; Pérez-Silanes S; Ravera M; Gabano E
Eur J Med Chem; 2019 Feb; 163():569-582. PubMed ID: 30554132
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
6. New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.
de Moraes Gomes PAT; de Oliveira Barbosa M; Farias Santiago E; de Oliveira Cardoso MV; Capistrano Costa NT; Hernandes MZ; Moreira DRM; da Silva AC; Dos Santos TAR; Pereira VRA; Brayner Dos Santosd FA; do Nascimento Pereira GA; Ferreira RS; Leite ACL
Eur J Med Chem; 2016 Oct; 121():387-398. PubMed ID: 27295485
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease.
Beltran-Hortelano I; Atherton RL; Rubio-Hernández M; Sanz-Serrano J; Alcolea V; Kelly JM; Pérez-Silanes S; Olmo F
Eur J Med Chem; 2021 Nov; 223():113646. PubMed ID: 34182359
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
[TBL] [Abstract][Full Text] [Related]
11. In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives.
Martin-Montes A; Santivañez-Veliz M; Moreno-Viguri E; Martín-Escolano R; Jiménez-Montes C; Lopez-Gonzalez C; Marín C; Sanmartín C; Gutiérrez Sánchez R; Sánchez-Moreno M; Pérez-Silanes S
Parasitology; 2017 Nov; 144(13):1783-1790. PubMed ID: 28789716
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
14. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
15. In vivo trypanosomicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against acute and chronic phases of Chagas disease.
Sánchez-Moreno M; Sanz AM; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macias I; Rosales MJ; Olmo F; Garcia-Aranda I; Campayo L; Cano C; Arrebola F; Yunta MJ
J Med Chem; 2011 Feb; 54(4):970-9. PubMed ID: 21229977
[TBL] [Abstract][Full Text] [Related]
16. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
17. Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
Ferreira DD; Sousa FS; Costa-Silva TA; Reimão JQ; Torrecilhas AC; Johns DM; Sear CE; Honorio KM; Lago JHG; Anderson EA; Tempone AG
Eur J Med Chem; 2019 Aug; 176():162-174. PubMed ID: 31103897
[TBL] [Abstract][Full Text] [Related]
18. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]